• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
HemoSense, Inc. makes products that monitor blood coagulation for patients taking the blood thinning drug, warfarin. Its INRatio System product offers handheld meters and disposable test strips that measure a patient's blood clotting time to minimize dangerous blood clotting and excessive bleeding. The company's monitoring systems are used by health care professionals as well as by patients at home. HemoSense sells its products through distributors (including Cardinal Health, Medline, and the McKesson Medical-Surgical) in the US and 14 other countries.
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
0 | 2007-11-06 | 0 | |
|
MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG MPM ASSET MANAGEMENT INVESTORS 2000B LLC MPM ASSET MANAGEMENT II LP MPM ASSET MANAGEMENT II LLC |
|
0 | 2007-11-06 | 0 |
|
DIPPEL WILLIAM EXEC. VP, OPERATIONS, R&D |
|
0 | 2007-11-06 | 0 |
|
0 | 2007-11-06 | 0 | |
|
STILL TIMOTHY I EXEC. VP, SALES AND MARKETING |
|
0 | 2007-11-06 | 0 |
|
SANGSTER GORDON CHIEF FINANCIAL OFFICER |
|
0 | 2007-11-06 | 0 |
|
0 | 2007-11-06 | 0 | |
|
0 | 2007-11-06 | 0 | |
|
0 | 2007-11-06 | 0 | |
|
MERSELIS JAMES D PRESIDENT, CEO |
|
0 | 2007-11-06 | 0 |
|
RUNDLE DOUGLAS D VP, QUALITY®ULATORY AFFAIRS |
|
0 | 2007-11-06 | 0 |
|
14,069 | 2007-02-21 | 0 | |
|
NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP MORRIS PETER |
|
1,772,151 | 2006-12-12 | 0 |
|
NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP |
|
1,772,151 | 2006-12-12 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
